Dexcom’s 15-day G7 gets FDA nod—Could this be the game-changer for glucose monitoring and stock momentum?
Dexcom’s FDA-approved G7 15 Day CGM delivers record wear time and accuracy—read how it’s transforming diabetes care and investor sentiment. Read More
Revolutionizing diabetes care: Dexcom G7 CGM System gets Health Canada nod
Dexcom, a notable player in real-time continuous glucose monitoring (rtCGM) globally, confirmed today that Health Canada has given its approval for the next-generation Dexcom G7 ... Read More